Actuate Therapeutics Statistics
Total Valuation
ACTU has a market cap or net worth of $69.00 million. The enterprise value is $54.42 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACTU has 23.71 million shares outstanding. The number of shares has increased by 151.07% in one year.
| Current Share Class | 23.71M |
| Shares Outstanding | 23.71M |
| Shares Change (YoY) | +151.07% |
| Shares Change (QoQ) | +9.97% |
| Owned by Insiders (%) | 5.17% |
| Owned by Institutions (%) | 7.47% |
| Float | 8.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.36 |
| P/TBV Ratio | 8.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.39
| Current Ratio | 2.39 |
| Quick Ratio | 2.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,110.88 |
Financial Efficiency
Return on equity (ROE) is -553.75% and return on invested capital (ROIC) is -350.26%.
| Return on Equity (ROE) | -553.75% |
| Return on Assets (ROA) | -120.40% |
| Return on Invested Capital (ROIC) | -350.26% |
| Return on Capital Employed (ROCE) | -270.08% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.85M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.49% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -67.49% |
| 50-Day Moving Average | 2.79 |
| 200-Day Moving Average | 5.75 |
| Relative Strength Index (RSI) | 56.88 |
| Average Volume (20 Days) | 224,302 |
Short Selling Information
The latest short interest is 653,203, so 2.75% of the outstanding shares have been sold short.
| Short Interest | 653,203 |
| Short Previous Month | 669,336 |
| Short % of Shares Out | 2.75% |
| Short % of Float | 7.90% |
| Short Ratio (days to cover) | 7.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.50M |
| Pretax Income | -22.23M |
| Net Income | -22.23M |
| EBITDA | n/a |
| EBIT | -22.50M |
| Earnings Per Share (EPS) | -$1.06 |
Full Income StatementBalance Sheet
The company has $13.16 million in cash and n/a in debt, giving a net cash position of $13.16 million or $0.55 per share.
| Cash & Cash Equivalents | 13.16M |
| Total Debt | n/a |
| Net Cash | 13.16M |
| Net Cash Per Share | $0.55 |
| Equity (Book Value) | 7.92M |
| Book Value Per Share | 0.34 |
| Working Capital | 7.94M |
Full Balance SheetCash Flow
| Operating Cash Flow | -19.21M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |